An observational study focusing on the changes of the upper eyelid sulcus after switching from FP receptor agonist to omidenepag isoproryl ophthalmic solutio
Not Applicable
- Conditions
- Glaucoma, ocular hypertension
- Registration Number
- JPRN-UMIN000036705
- Lead Sponsor
- Yotsuya Shirato Eye Clinic
- Brief Summary
https://pubmed.ncbi.nlm.nih.gov/36318495/
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
1) a patient with aphakic or pseudophakic eyes 2) a patient with hypersensitivity to Omidenepag isopropyl ophthalmic solution 0.002%
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of findings and subjective symptom and quality of life about the upper eyelid sulcus
- Secondary Outcome Measures
Name Time Method